LOCUS       MF195739                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/233/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195739
VERSION     MF195739.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/233/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/233/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/233/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/233/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007671"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="18-Apr-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31975.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFKNESFNWTGVTQNGTSSACIRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPGTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIESIRNETYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaatggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa aaatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcggaaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca tagaatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 agatgcaaca tttgcatttg a
//
LOCUS       MF195738                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/231/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195738
VERSION     MF195738.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/231/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/231/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/231/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/231/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007670"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="14-Apr-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31974.1"
                     /translation="MKTIIALSYILCLVFAQKIPGDDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSMGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFKNESFNWTGVTQNGTSSACIRGSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPGTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIGSIRNETYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggagatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaacggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa tgggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa aaatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gggatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcggaaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca taggatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 agatgcaaca tttgcatttg a
//
LOCUS       MF195737                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/196/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195737
VERSION     MF195737.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/196/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/196/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/196/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/196/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007637"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="14-Mar-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31973.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNGNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFNNESFNWTGVTQNGTSSACIRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNNEQFDKLYIWGVHHPGTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIGSIRNGTYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatggca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaacggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agaaaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggaatttaa caatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata cccagcattg
      541 aacgtgacta tgccaaacaa tgaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg acggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcgggaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agaattcagg accttgagaa atatgttgag gacactaaaa tcgatctctg gtcatataac
     1321 gcggagcttc ttgttgccct ggaaaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca taggatcaat aagaaatgga
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaagggg
     1561 gttgagctga agtcagggta caaagattgg attctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa aggcaacatt
     1681 aggtgcaaca tttgcatttg a
//
LOCUS       MF195736                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/144/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195736
VERSION     MF195736.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/144/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/144/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/144/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/144/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007594"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="08-Mar-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31972.1"
                     /translation="MKTIIALSYILCLVFAQKLPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFNNESFNWAGVTQNGTSSSCIRGSNSSF
                     FSRLNWLTHLNSKYPALNVTMPNNEQFDKLYIWGVHHPGTDKDQIFLYAQPSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKQNTLKLATGMRNVP
                     ERQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRIQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIGSIRNGTYDHDVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaacttcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaacggaacg
      121 atagtgaaaa caatcacgaa tgaccgaatt gaagttacta atgctactga gctggttcag
      181 aattcctcaa taggtgaaat atgcgacagt ccccatcaga tccttgatgg agaaaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gatttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa caatgaaagc
      421 ttcaattggg ctggagtcac tcaaaacgga acaagttctt cttgcataag gggatctaat
      481 agtagtttct ttagtagatt aaattggttg acccacttaa attccaaata tccagcatta
      541 aatgtgacta tgccaaacaa tgaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgcacaac catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccgaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca aaacactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagagacaaa ctagaggcat atttggcgca atagcaggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggcttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatt gatcaaatca atgggaagct gaatcgattg
     1201 atcgggaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaaggg
     1261 agaattcagg accttgagaa atatgttgag gacacaaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggcaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca taggatcaat cagaaatgga
     1501 acttatgacc acgatgtata cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 aggtgcaaca tttgcatttg a
//
LOCUS       MF195735                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/086/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195735
VERSION     MF195735.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/086/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/086/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/086/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/086/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007543"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="24-Feb-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31971.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFKNESFNWTGVTQNGTSSACIRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPGTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIGSIRNETYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaacggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa aaatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcggaaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca taggatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 agatgcaaca tttgcatttg a
//
LOCUS       MF195734                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/068/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195734
VERSION     MF195734.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/068/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/068/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/068/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/068/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007527"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="18-Feb-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31970.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFKNESFNWTGVTQNGTSSACIRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPSTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIESIRNETYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaatggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa aaatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgagtacgg acaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcggaaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca tagaatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 agatgcaaca tttgcatttg a
//
LOCUS       MF195733                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/051/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195733
VERSION     MF195733.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/051/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/051/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/051/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/051/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007510"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="13-Feb-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31969.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFKNESFNWTGVTQNGTSSACIRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPGTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIGSIRNETYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaacggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa aaatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tccaccaaaa gaagccaaca agctgtaatc ccaaatatag gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcggaaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaaggg
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca taggatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 agatgcaaca tttgcatttg a
//
LOCUS       MF195732                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/049/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195732
VERSION     MF195732.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/049/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/049/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/049/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/049/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007508"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="11-Feb-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31968.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFKNESFNWTGVTQNGTSSACIRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPGTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIGSIRNETYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc maacggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa aaatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgctcaat catcgggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcgggaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca taggatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatc
     1681 agatgcaaca tttgcatttg a
//
LOCUS       MF195731                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/047/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195731
VERSION     MF195731.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/047/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/047/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/047/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/047/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007506"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="09-Feb-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31967.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFNNESFNWTGVTQNGTSSACIRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPGTEKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIGSIRNETYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaacggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa caatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg aaaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttccaaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtgcca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcgggaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaagctgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca taggatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 agatgcaaca tttgcatttg a
//
LOCUS       MF195730                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/045/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195730
VERSION     MF195730.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/045/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/045/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/045/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/045/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007505"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="09-Feb-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31966.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFKNESFNWTGVTQNGTSSACIRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPGTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIGSIRNETYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaacggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa aaatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct agaggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcggaaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca taggatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 agatgcaaca tttgcatttg a
//
LOCUS       MF195729                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/040/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195729
VERSION     MF195729.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/040/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/040/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/040/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/040/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007501"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="03-Feb-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31965.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFKNESFNWTGVTQNGTSSACIRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPGTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIGSIRNETYDHNVYRDEALNNRFQ
                     IKGXELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaacggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa aaatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcataag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct agaggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcggaaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca taggatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 rttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 agatgcaaca tttgcatttg a
//
LOCUS       MF195728                1701 bp    cRNA    linear   VRL 24-JUN-2017
DEFINITION  Influenza A virus (A/Ontario/031/2016(H3N2)) segment 4 hemagglutinin
            (HA) gene, complete cds.
ACCESSION   MF195728
VERSION     MF195728.1
KEYWORDS    .
SOURCE      Influenza A virus (A/Ontario/031/2016(H3N2))
  ORGANISM  Influenza A virus (A/Ontario/031/2016(H3N2))
            Viruses; ssRNA viruses; ssRNA negative-strand viruses;
            Orthomyxoviridae; Influenzavirus A.
REFERENCE   1  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Influenza vaccine effectiveness during the 2015-16 season in Canada:
            agent-host and immuno-epidemiological influences beyond antigenic
            match
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 1701)
  AUTHORS   Skowronski,D.M., Chambers,C., Sabaiduc,S., De Serres,G.,
            Winter,A.-L., Dickinson,J.A., Gubbay,J.B., Drews,S.J., Charest,H.,
            Bastien,N., Li,Y. and Krajden,M.
  CONSRTM   Canadian Sentinel Practitioner Surveillance Network (SPSN)
  TITLE     Direct Submission
  JOURNAL   Submitted (05-JUN-2017) Clinical Trials, British Columbia Centre for
            Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
COMMENT     ##Assembly-Data-START##
            Assembly Method       :: Geneious v. 7.1.9
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..1701
                     /organism="Influenza A virus (A/Ontario/031/2016(H3N2))"
                     /mol_type="viral cRNA"
                     /strain="A/Ontario/031/2016"
                     /serotype="H3N2"
                     /isolation_source="nasopharyngeal wash"
                     /host="Homo sapiens"
                     /db_xref="taxon:2007499"
                     /segment="4"
                     /country="Canada: Ontario"
                     /collection_date="18-Jan-2016"
                     /note="passage details: original specimen"
     gene            1..1701
                     /gene="HA"
     CDS             1..1701
                     /gene="HA"
                     /function="receptor binding and fusion protein"
                     /codon_start=1
                     /product="hemagglutinin"
                     /protein_id="ASB31964.1"
                     /translation="MKTIIALSYILCLVFAQKIPGNDNSTATLCLGHHAVPNGTIVKTI
                     TNDRIEVTNATELVQNSSIGEICDSPHQILDGENCTLIDALLGDPQCDGFQNKKWDLFV
                     ERSKAYSNCYPYDVPDYASLRSLVASSGTLEFKNESFNWTGVTQNGTSSACMRRSSSSF
                     FSRLNWLTHLNYTYPALNVTMPNKEQFDKLYIWGVHHPGTDKDQIFLYAQSSGRITVST
                     KRSQQAVIPNIGSRPRIRDIPSRISIYWTIVKPGDILLINSTGNLIAPRGYFKIRSGKS
                     SIMRSDAPIGKCKSECITPNGSIPNDKPFQNVNRITYGACPRYVKHSTLKLATGMRNVP
                     EKQTRGIFGAIAGFIENGWEGMVDGWYGFRHQNSEGRGQAADLKSTQAAIDQINGKLNR
                     LIGKTNEKFHQIEKEFSEVEGRVQDLEKYVEDTKIDLWSYNAELLVALENQHTIDLTDS
                     EMNKLFEKTKKQLRENAEDMGNGCFKIYHKCDNACIESIRNETYDHNVYRDEALNNRFQ
                     IKGVELKSGYKDWILWISFAISCFLLCVALLGFIMWACQKGNIRCNICI"
     sig_peptide     1..48
                     /gene="HA"
     mat_peptide     49..1035
                     /gene="HA"
                     /product="HA1"
     mat_peptide     1036..1698
                     /gene="HA"
                     /product="HA2"
ORIGIN
        1 atgaagacta tcattgcttt gagctacatt ctatgtctgg ttttcgctca aaaaattcct
       61 ggaaatgaca atagcacggc aacgctgtgc cttgggcacc atgcagtacc aaatggaacg
      121 atagtgaaaa caatcacaaa tgaccgaatt gaagttacta atgctactga gttggttcag
      181 aattcctcaa taggtgaaat atgcgacagt cctcatcaga tccttgatgg agagaactgc
      241 acactaatag atgctctatt gggagaccct cagtgtgatg gctttcaaaa taagaaatgg
      301 gacctttttg ttgaacgaag caaagcctac agcaactgtt acccttatga tgtgccggat
      361 tatgcctccc ttaggtcact agttgcctca tccggcacac tggagtttaa aaatgaaagc
      421 ttcaattgga ctggagtcac tcaaaacgga acaagttctg cttgcatgag gagatctagt
      481 agtagtttct ttagtagatt aaattggttg acccacttaa actacacata tccagcattg
      541 aacgtgacta tgccaaacaa ggaacaattt gacaaattgt acatttgggg ggttcaccac
      601 ccgggtacgg acaaggacca aatcttcctg tatgctcaat catcaggaag aatcacagta
      661 tctaccaaaa gaagccaaca agctgtaatc ccaaatatcg gatctagacc cagaataagg
      721 gatatcccta gcagaataag catctattgg acaatagtaa aaccgggaga catacttttg
      781 attaacagca cagggaatct aattgctcct aggggttact tcaaaatacg aagtgggaaa
      841 agctcaataa tgagatcaga tgcacccatt ggcaaatgca agtctgaatg catcactcca
      901 aatggaagca ttcccaatga caaaccattc caaaatgtaa acaggatcac atacggggcc
      961 tgtcccagat atgttaagca tagcactctg aaattggcaa caggaatgcg aaatgtacca
     1021 gagaaacaaa ctagaggcat atttggcgca atagcgggtt tcatagaaaa tggttgggag
     1081 ggaatggtgg atggttggta cggtttcagg catcaaaatt ctgagggaag aggacaagca
     1141 gcagatctca aaagcactca agcagcaatc gatcaaatca atgggaagct gaatcggttg
     1201 atcggaaaaa ccaacgagaa attccatcag attgaaaaag aattctcaga agtagaagga
     1261 agagttcaag accttgagaa atatgttgag gacactaaaa tagatctctg gtcatacaac
     1321 gcggagcttc ttgttgccct ggagaaccaa catacaattg atctaactga ctcagaaatg
     1381 aacaaactgt ttgaaaaaac aaagaagcaa ctgagggaaa atgctgagga tatgggaaat
     1441 ggttgtttca aaatatacca caaatgtgac aatgcctgca tagaatcaat aagaaatgaa
     1501 acttatgacc acaatgtgta cagggatgaa gcattaaaca accggttcca gatcaaggga
     1561 gttgagctga agtcagggta caaagattgg atcctatgga tttcctttgc catatcatgt
     1621 tttttgcttt gtgttgcttt gttggggttc atcatgtggg cctgccaaaa gggcaacatt
     1681 agatgcaaca tttgcatttg a
//
